242 GENES FOUND
Show / hide columns
XML |
RDF |
TSV |
Page next »
IH abundance (Normal Tissue)
x
RNA abundance (Normal Tissue)
x
ABCA5 ATP-binding cassette, sub-family A (ABC1), member 5
Pancreatic cancer: 9.97e-5 Expressed in all
ABCB5 ATP-binding cassette, sub-family B (MDR/TAP), member 5 N/A
Tissue enriched 7 epididymis: 31.7
ABCB8 ATP-binding cassette, sub-family B (MDR/TAP), member 8
Nucleus Pancreatic cancer: 3.34e-4 Renal cancer: 5.88e-4 Head and neck cancer: 5.91e-4 Expressed in all
ABCC2 ATP-binding cassette, sub-family C (CFTR/MRP), member 2
Renal cancer: 1.93e-5 Group enriched 10 duodenum: 44.7 gallbladder: 42.8 kidney: 20.8 liver: 67.6 small intestine: 50.5
ABCD3 ATP-binding cassette, sub-family D (ALD), member 3
Peroxisomes Colorectal cancer: 1.16e-5 Renal cancer: 4.84e-5 Expressed in all
ABCD4 ATP-binding cassette, sub-family D (ALD), member 4
Expressed in all
ACKR2 Atypical chemokine receptor 2
Nucleoplasm Tissue enhanced placenta: 22.8
ADCY10 Adenylate cyclase 10 (soluble)
Tissue enriched 11 testis: 32.9
ADCY3 Adenylate cyclase 3
Renal cancer: 1.32e-9 Expressed in all
ADCY7 Adenylate cyclase 7
Cytosol Cervical cancer: 5.31e-4 Mixed
ADGRE1 Adhesion G protein-coupled receptor E1
Tissue enhanced appendix: 10.2 spleen: 20.1
ADRA2C Adrenoceptor alpha 2C N/A
Tissue enhanced cervix, uterine: 21.0 endometrium: 26.0 seminal vesicle: 26.7
ALG8 ALG8, alpha-1,3-glucosyltransferase
Nucleoplasm Expressed in all
ANO1 Anoctamin 1, calcium activated chloride channel
Renal cancer: 4.09e-6 Endometrial cancer: 4.58e-6 Head and neck cancer: 7.28e-5 Pancreatic cancer: 1.70e-4 Lung cancer: 2.40e-4 Tissue enhanced epididymis: 217.7 seminal vesicle: 295.7
ANO8 Anoctamin 8
Nucleoplasm Tissue enhanced cerebral cortex: 34.6
AQP10 Aquaporin 10
Group enriched 8 duodenum: 70.3 small intestine: 50.1
AQP4 Aquaporin 4
Plasma membrane Group enriched 17 cerebral cortex: 631.8 lung: 172.2
ARL6IP1 ADP-ribosylation factor-like 6 interacting protein 1
Endoplasmic reticulum Expressed in all
ARV1 ARV1 homolog, fatty acid homeostasis modulator
Vesicles Lung cancer: 3.27e-5 Colorectal cancer: 1.33e-4 Expressed in all
ATP10D ATPase, class V, type 10D
Nucleoplasm Renal cancer: 5.00e-8 Mixed
ATP11B ATPase, class VI, type 11B
Microtubule organizing center Pancreatic cancer: 1.09e-4 Endometrial cancer: 3.44e-4 Expressed in all
ATP13A4 ATPase type 13A4
Nucleoplasm Head and neck cancer: 3.91e-4 Tissue enhanced epididymis: 89.1 parathyroid gland: 129.5 thyroid gland: 68.2
ATP6V0B ATPase, H+ transporting, lysosomal 21kDa, V0 subunit b
Cytosol Renal cancer: 3.62e-6 Pancreatic cancer: 3.24e-4 Liver cancer: 4.79e-4 Urothelial cancer: 8.87e-4 Expressed in all
ATP7B ATPase, Cu++ transporting, beta polypeptide
Golgi apparatus Endometrial cancer: 5.01e-4 Mixed
C5orf28 Chromosome 5 open reading frame 28
Nucleoplasm Liver cancer: 1.59e-4 Renal cancer: 2.85e-4 Expressed in all
CACNA1G Calcium channel, voltage-dependent, T type, alpha 1G subunit N/A
Tissue enhanced cerebral cortex: 10.6 cervix, uterine: 8.5
CATSPER4 Cation channel, sperm associated 4
Tissue enriched 63 testis: 9.7
CCR7 Chemokine (C-C motif) receptor 7
Mitochondria Head and neck cancer: 7.61e-7 Cervical cancer: 8.03e-6 Breast cancer: 3.84e-4 Testis cancer: 7.72e-4 Group enriched 6 appendix: 91.9 lymph node: 98.3 spleen: 39.9 tonsil: 80.2
CCRL2 Chemokine (C-C motif) receptor-like 2
Colorectal cancer: 3.72e-5 Urothelial cancer: 9.67e-5 Mixed
CD47 CD47 molecule
Golgi apparatus Thyroid cancer: 7.29e-5 Renal cancer: 1.69e-4 Endometrial cancer: 2.44e-4 Expressed in all
CDIPT CDP-diacylglycerol--inositol 3-phosphatidyltransferase
Nucleoplasm Cervical cancer: 9.40e-4 Expressed in all
CERS1 Ceramide synthase 1
Endoplasmic reticulum Group enriched 13 cerebral cortex: 136.6 testis: 28.0
CLN6 Ceroid-lipofuscinosis, neuronal 6, late infantile, variant
Vesicles Renal cancer: 4.87e-4 Expressed in all
CLPTM1 Cleft lip and palate associated transmembrane protein 1
Nuclear membrane Expressed in all
CMTM1 CKLF-like MARVEL transmembrane domain containing 1
Nucleoplasm Pancreatic cancer: 5.68e-5 Tissue enriched 6 testis: 28.8
CNGA1 Cyclic nucleotide gated channel alpha 1
Vesicles Mixed
CNGA2 Cyclic nucleotide gated channel alpha 2 N/A
Not detected
CNGB1 Cyclic nucleotide gated channel beta 1 N/A
Vesicles Mixed
CNGB3 Cyclic nucleotide gated channel beta 3
Tissue enhanced testis: 4.0
CNNM2 Cyclin and CBS domain divalent metal cation transport mediator 2
Vesicles Renal cancer: 2.39e-8 Tissue enhanced parathyroid gland: 33.5
CYB561 Cytochrome b561
Endometrial cancer: 2.95e-5 Breast cancer: 8.89e-5 Expressed in all
CYB561A3 Cytochrome b561 family, member A3
Expressed in all
CYBRD1 Cytochrome b reductase 1
Golgi apparatus Expressed in all
DAGLB Diacylglycerol lipase, beta
Plasma membrane Ovarian cancer: 7.18e-5 Renal cancer: 1.54e-4 Expressed in all
DEGS1 Delta(4)-desaturase, sphingolipid 1
Mitochondria Renal cancer: 6.83e-7 Liver cancer: 4.29e-5 Endometrial cancer: 7.74e-5 Urothelial cancer: 2.53e-4 Expressed in all
DERL2 Derlin 2
Endoplasmic reticulum Renal cancer: 6.49e-4 Endometrial cancer: 7.26e-4 Expressed in all
DERL3 Derlin 3
Vesicles Renal cancer: 7.76e-13 Cervical cancer: 8.70e-5 Head and neck cancer: 8.01e-4 Mixed
DPY19L2 Dpy-19-like 2 (C. elegans)
Nucleus Tissue enriched 8 testis: 111.5
DUOXA1 Dual oxidase maturation factor 1
Tissue enhanced esophagus: 122.6 skin: 107.8 thyroid gland: 111.5
DUOXA2 Dual oxidase maturation factor 2
Tissue enhanced gallbladder: 97.7 urinary bladder: 25.6
Page next »
